RAPID grows international footprint and brings Mexico the only clinically validated, next-
generation imaging platform for assessing ischemic stroke
Menlo Park, Calif. — June 18, 2019 – iSchemaView, the worldwide leader in advanced imaging for stroke, has expanded its reach across North and Latin America, as the RAPID imaging platform is now available for use in Mexico. RAPID is designed to provide physicians with fully automated and easy-to-interpret imaging that facilitates timely clinical decision-making around stroke.
“Strokes are a medical emergency, and urgent treatment is essential. The sooner a person receives treatment for a stroke, the less damage is likely to happen. That’s why Punta Mita Hospital has acquired the most advanced cerebrovascular imaging platform available, RAPID,” offered Dr. Luis Alberto López Avelar, Medical Director Punta Mita Hospital. “We are committed to offering the best quality in medical care, which is why now with RAPID Punta Mita Hospital provides state-of-the-art technology for the timely and accurate diagnosis of a cerebrovascular event.”
Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring).
Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems.
The Complete RAPID Platform includes:
- RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced
cerebral blood flow, cerebral blood volume and transit time
- RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain
areas with low ADC values, as well as delayed contrast arrival
- RAPID CTA: automatically delivers CT angiography maps and identifies brain
regions with reduced blood vessel density in 2D and 3D outputs
- RAPID ASPECTS: automatically identifies areas of early ischemic change on
non-contrast CT scans, which predicts irreversible injury
“Each day we work to transform stroke care, furthering our mission to provide healthcare professionals around the globe with the most comprehensive and intuitive suite of brain imaging solutions possible.” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “Based on just the first quarter of this year, RAPID is already on pace to image over 132,500 patients in 2019, process over 250,000 scans
and identify over 40,000 potential patients for thrombectomies. We will continue to expand, across Mexico and the globe, to provide as many hospitals as possible the tools they need to best help their patients and improve outcomes.”
iSchemaView is the worldwide leader in advanced imaging for stroke. Installed in over 1,200 hospitals, iSchemaView’s RAPID (automated CTP, MR, CTA and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform. In clinical trials, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit www.RAPID.ai